DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr | ₹41 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-1,045 Cr |
Mar2022 | ₹-816 Cr |
Mar2021 | ₹1,987 Cr |
Mar2020 | ₹41 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-1,045 Cr | Negative | |
Mar2022 | ₹-816 Cr | Negative | |
Mar2021 | ₹1,987 Cr | 4,740.85 | |
Mar2020 | ₹41 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹159,556.2 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
MANKIND PHARMA | ₹103,060.0 Cr | -0.8% | -2% | 11.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.1% |
1.5% |
61.3% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses